AD is also characterized by dysregulation of glucose metabolism [63,64,65,66], and a recent study found that inflammation initiated by elevated glucose levels in the BV2 microglial cell line results in a higher rate of NLRP3 inflammasome activation [23]. The gene discussed is NLRP3; the disease is Alzheimer disease.